Cargando…
The Microbiome Tumor Axis: How the Microbiome Could Contribute to Clonal Heterogeneity and Disease Outcome in Pancreatic Cancer
Pancreatic ductal adenocarcinoma (PDAC) is one of the most malignant cancers. It is characterized by a poor prognosis with a 5-year survival rate of only around 10% and an ongoing increase in death rate. Due to the lack of early and specific symptoms, most patients are diagnosed at an advanced or ev...
Autores principales: | Basu, Meghna, Philipp, Lisa-Marie, Baines, John F., Sebens, Susanne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495218/ https://www.ncbi.nlm.nih.gov/pubmed/34631577 http://dx.doi.org/10.3389/fonc.2021.740606 |
Ejemplares similares
-
Contribution of Epithelial and Gut Microbiome Inflammatory Biomarkers to the Improvement of Colorectal Cancer Patients’ Stratification
por: Ionica, Elena, et al.
Publicado: (2022) -
Vinegar could act by gut microbiome
por: Luo, Dan, et al.
Publicado: (2019) -
Intratumoral microbiome and gastrointestinal cancers
por: Li, Shengnan, et al.
Publicado: (2022) -
Prediction of Pathogenic Factors in Dysbiotic Gut Microbiomes of Colorectal Cancer Patients Using Reverse Microbiomics
por: Wang, Haihe, et al.
Publicado: (2022) -
Transcriptional Heterogeneity and the Microbiome of Cutaneous T-Cell Lymphoma
por: Licht, Philipp, et al.
Publicado: (2022)